NDUFA3P2

Across TCGA pan-cancer cohorts, NDUFA3P2 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of NDUFA3P2’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where NDUFA3P2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types NDUFA3P2 is over-expressed in tumor.

KIRC and HNSC are the cancer types where NDUFA3P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in NDUFA3P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	III,IV	+0.131	.002	6	view →
HNSC	All	IV	+0.134	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

NDUFA3P2–KIRC

Open the KIRC breakdown →